Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Alzamend Neuro, Inc.

NASDAQ: ALZN · Life Sciences · 2 alerts · CIK 1677077

Share price
$1.18Close, Nov 16
Market cap
$5.69M
Shares outstanding
4.83MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Alzamend Neuro, Inc. filings on SEC EDGAR ↗

4:31 PM ET 8-K/A
Capital Raise

Alzamend Neuro Capital Raise of $10M

Alzamend Neuro entered into an Amended and Restated Securities Purchase Agreement with Ault Lending, LLC to sell $10 million in Series D convertible preferred stock. This amends a previous agreement for $25 million, with $7.5 million already raised in an initial tranche and an additional $2.5 million committed for a second tranche closing.

Value
$10M
Counterparty
Ault Lending, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.